BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chen EM, Quijano AR, Seo YE, Jackson C, Josowitz AD, Noorbakhsh S, Merlettini A, Sundaram RK, Focarete ML, Jiang Z, Bindra RS, Saltzman WM. Biodegradable PEG-poly(ω-pentadecalactone-co-p-dioxanone) nanoparticles for enhanced and sustained drug delivery to treat brain tumors. Biomaterials 2018;178:193-203. [PMID: 29936153 DOI: 10.1016/j.biomaterials.2018.06.024] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 6.8] [Reference Citation Analysis]
Number Citing Articles
1 Sun Y, Li L, Xie H, Wang Y, Gao S, Zhang L, Bo F, Yang S, Feng A. Primary Studies on Construction and Evaluation of Ion-Sensitive in situ Gel Loaded with Paeonol-Solid Lipid Nanoparticles for Intranasal Drug Delivery. Int J Nanomedicine 2020;15:3137-60. [PMID: 32440115 DOI: 10.2147/IJN.S247935] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
2 Yokel RA. Nanoparticle brain delivery: a guide to verification methods. Nanomedicine 2020;15:409-32. [DOI: 10.2217/nnm-2019-0169] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
3 Ngowi EE, Wang YZ, Qian L, Helmy YASH, Anyomi B, Li T, Zheng M, Jiang ES, Duan SF, Wei JS, Wu DD, Ji XY. The Application of Nanotechnology for the Diagnosis and Treatment of Brain Diseases and Disorders. Front Bioeng Biotechnol 2021;9:629832. [PMID: 33738278 DOI: 10.3389/fbioe.2021.629832] [Reference Citation Analysis]
4 Xu Y, Wei L, Wang H. Progress and perspectives on nanoplatforms for drug delivery to the brain. Journal of Drug Delivery Science and Technology 2020;57:101636. [DOI: 10.1016/j.jddst.2020.101636] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
5 Tinajero-díaz E, Martínez de Ilarduya A, Muñoz-guerra S. Synthesis and properties of diblock copolymers of ω-pentadecalactone and α-amino acids. European Polymer Journal 2019;116:169-79. [DOI: 10.1016/j.eurpolymj.2019.04.009] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
6 Shen S, Li Y, Xiao Y, Zhao Z, Zhang C, Wang J, Li H, Liu F, He N, Yuan Y, Lu Y, Guo S, Wang Y, Liao W, Liao Y, Chen Y, Bin J. Folate-conjugated nanobubbles selectively target and kill cancer cells via ultrasound-triggered intracellular explosion. Biomaterials 2018;181:293-306. [PMID: 30096563 DOI: 10.1016/j.biomaterials.2018.07.030] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 6.3] [Reference Citation Analysis]
7 Zhu J, Jiang G, Hong W, Zhang Y, Xu B, Song G, Liu T, Hong C, Ruan L. Rapid gelation of oxidized hyaluronic acid and succinyl chitosan for integration with insulin-loaded micelles and epidermal growth factor on diabetic wound healing. Mater Sci Eng C Mater Biol Appl 2020;117:111273. [PMID: 32919637 DOI: 10.1016/j.msec.2020.111273] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 5.5] [Reference Citation Analysis]
8 Teleanu DM, Chircov C, Grumezescu AM, Volceanov A, Teleanu RI. Impact of Nanoparticles on Brain Health: An Up to Date Overview. J Clin Med 2018;7:E490. [PMID: 30486404 DOI: 10.3390/jcm7120490] [Cited by in Crossref: 61] [Cited by in F6Publishing: 41] [Article Influence: 15.3] [Reference Citation Analysis]
9 Meng D, Guo L, Shi D, Sun X, Shang M, Zhou X, Li J. Charge-conversion and ultrasound-responsive O-carboxymethyl chitosan nanodroplets for controlled drug delivery. Nanomedicine (Lond) 2019;14:2549-65. [PMID: 31271101 DOI: 10.2217/nnm-2019-0217] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 3.7] [Reference Citation Analysis]
10 Barnieh FM, Loadman PM, Falconer RA. Progress towards a clinically-successful ATR inhibitor for cancer therapy. Current Research in Pharmacology and Drug Discovery 2021;2:100017. [DOI: 10.1016/j.crphar.2021.100017] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
11 Jin P, Sha R, Zhang Y, Liu L, Bian Y, Qian J, Qian J, Lin J, Ishimwe N, Hu Y, Zhang W, Liu Y, Yin S, Ren L, Wen LP. Blood Circulation-Prolonging Peptides for Engineered Nanoparticles Identified via Phage Display. Nano Lett 2019;19:1467-78. [PMID: 30730145 DOI: 10.1021/acs.nanolett.8b04007] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
12 Wolpaw AJ, Bayliss R, Büchel G, Dang CV, Eilers M, Gustafson WC, Hansen GH, Jura N, Knapp S, Lemmon MA, Levens D, Maris JM, Marmorstein R, Metallo SJ, Park JR, Penn LZ, Rape M, Roussel MF, Shokat KM, Tansey WP, Verba KA, Vos SM, Weiss WA, Wolf E, Mossé YP. Drugging the "Undruggable" MYCN Oncogenic Transcription Factor: Overcoming Previous Obstacles to Impact Childhood Cancers. Cancer Res 2021;81:1627-32. [PMID: 33509943 DOI: 10.1158/0008-5472.CAN-20-3108] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
13 Seo YE, Suh HW, Bahal R, Josowitz A, Zhang J, Song E, Cui J, Noorbakhsh S, Jackson C, Bu T, Piotrowski-Daspit A, Bindra R, Saltzman WM. Nanoparticle-mediated intratumoral inhibition of miR-21 for improved survival in glioblastoma. Biomaterials 2019;201:87-98. [PMID: 30802686 DOI: 10.1016/j.biomaterials.2019.02.016] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 11.7] [Reference Citation Analysis]
14 Cano A, Espina M, García ML. Recent Advances on Antitumor Agents-loaded Polymeric and Lipid-based Nanocarriers for the Treatment of Brain Cancer. Curr Pharm Des 2020;26:1316-30. [PMID: 31951159 DOI: 10.2174/1381612826666200116142922] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
15 Melancon MP, Yevich S, Avritscher R, Swigost A, Lu L, Tian L, Damasco JA, Dixon K, Cortes AC, Munoz NM, Liang D, Liu D, Tam AL. A novel irinotecan-lipiodol nanoemulsion for intravascular administration: pharmacokinetics and biodistribution in the normal and tumor bearing rat liver. Drug Deliv 2021;28:240-51. [PMID: 33501859 DOI: 10.1080/10717544.2020.1869863] [Reference Citation Analysis]
16 Hsu JF, Chu SM, Liao CC, Wang CJ, Wang YS, Lai MY, Wang HC, Huang HR, Tsai MH. Nanotechnology and Nanocarrier-Based Drug Delivery as the Potential Therapeutic Strategy for Glioblastoma Multiforme: An Update. Cancers (Basel) 2021;13:E195. [PMID: 33430494 DOI: 10.3390/cancers13020195] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
17 Hu X, Yang F, Liao Y, Li L, Zhao G, Zhang L. Docetaxel-Loaded Cholesterol-PEG Co-Modified Poly (n-Butyl) Cyanoacrylate Nanoparticles for Antitumor Drug Pulmonary Delivery: Preparation, Characterization, and in vivo Evaluation. Int J Nanomedicine 2020;15:5361-76. [PMID: 32801694 DOI: 10.2147/IJN.S249511] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Chen J, Li L, Gao J. Biomaterials for local drug delivery in central nervous system. International Journal of Pharmaceutics 2019;560:92-100. [DOI: 10.1016/j.ijpharm.2019.01.071] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
19 Teleanu DM, Chircov C, Grumezescu AM, Teleanu RI. Neuronanomedicine: An Up-to-Date Overview. Pharmaceutics 2019;11:E101. [PMID: 30813646 DOI: 10.3390/pharmaceutics11030101] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 6.3] [Reference Citation Analysis]
20 Nosrati H, Abhari F, Charmi J, Davaran S, Danafar H. Multifunctional nanoparticles from albumin for stimuli-responsive efficient dual drug delivery. Bioorg Chem 2019;88:102959. [PMID: 31075743 DOI: 10.1016/j.bioorg.2019.102959] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
21 Gorecki L, Andrs M, Rezacova M, Korabecny J. Discovery of ATR kinase inhibitor berzosertib (VX-970, M6620): Clinical candidate for cancer therapy. Pharmacol Ther 2020;210:107518. [PMID: 32109490 DOI: 10.1016/j.pharmthera.2020.107518] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 8.0] [Reference Citation Analysis]
22 Khan NU, Ni J, Ju X, Miao T, Chen H, Han L. Escape from abluminal LRP1-mediated clearance for boosted nanoparticle brain delivery and brain metastasis treatment. Acta Pharm Sin B 2021;11:1341-54. [PMID: 34094838 DOI: 10.1016/j.apsb.2020.10.015] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
23 Heravi Shargh V, Luckett J, Bouzinab K, Paisey S, Turyanska L, Singleton WGB, Lowis S, Gershkovich P, Bradshaw TD, Stevens MFG, Bienemann A, Coyle B. Chemosensitization of Temozolomide-Resistant Pediatric Diffuse Midline Glioma Using Potent Nanoencapsulated Forms of a N(3)-Propargyl Analogue. ACS Appl Mater Interfaces 2021;13:35266-80. [PMID: 34310112 DOI: 10.1021/acsami.1c04164] [Reference Citation Analysis]
24 Karimy JK, Reeves BC, Kahle KT. Targeting TLR4-dependent inflammation in post-hemorrhagic brain injury. Expert Opin Ther Targets 2020;24:525-33. [PMID: 32249624 DOI: 10.1080/14728222.2020.1752182] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]